DEFA14A: Additional proxy soliciting materials – definitive Post author:andrewkaretas Post published:April 30, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingDEFA14A: Additional proxy soliciting materials – definitive
ARS: An annual report to security holders Post author:andrewkaretas Post published:April 30, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingARS: An annual report to security holders
DEF 14A: Official notification to shareholders of matters to be brought to a vote (“Proxy”) Post author:andrewkaretas Post published:April 30, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingDEF 14A: Official notification to shareholders of matters to be brought to a vote (“Proxy”)
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:April 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing Post author:andrewkaretas Post published:April 21, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing
SCHEDULE 13G/A: SCHEDULE 13G/A – Description Post author:andrewkaretas Post published:April 17, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingSCHEDULE 13G/A: SCHEDULE 13G/A – Description
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:March 18, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:March 18, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing Post author:andrewkaretas Post published:March 14, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing
144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing Post author:andrewkaretas Post published:March 14, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing
